Performance evaluation of four antibiotics using the BD Phoenix™ NMIC-413 antimicrobial susceptibility testing panel for carbapenem-resistant <i>Enterobacteriaceae</i> and carbapenem-resistant <i>Pseudomonas aeruginosa</i>.

Front Microbiol · 2025 · PMC12271110 · PMID 40687849

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp < 0.001actually significant

All comparisons demonstrated highly significant concordance ( p < 0.001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Performance evaluation of four antibiotics using the BD Phoenix™ NMIC-413 antimicrobial susceptibility testing panel for carbapenem-resistant &lt;i&gt;Enterobacteriaceae&lt;/i&gt; and carbapenem-resistant &lt;i&gt;Pseudomonas aeruginosa&lt;/i&gt;.

The sentences

Performance evaluation of four antibiotics using the BD Phoenix™ NMIC-413 antimicrobial susceptibility testing panel for carbapenem-resistant <i>Enterobacteriaceae</i> and carbapenem-resistant <i>Pseudomonas aeruginosa</i>.